Clinical Trial Update: Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism [NA]

View source ↗

Summary

This clinical trial update examines the prognostic value of heart-type fatty acid-binding protein (h-FABP) as a biomarker in acute pulmonary embolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Pulmonary Embolism | NA | Status: COMPLETED